Bank of Montreal Can raised its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 10.0% in the third quarter, ...

SHANGHAI (Reuters) -Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in ...

Sanofi's new plan will require institutions to provide pharmacy ... President-elect Donald Trump on Monday pledged big ...

Beyfortus is the first long-acting antibody approved in Canada for the prevention of RSV lower respiratory tract disease in newborns and infants through their first RSV season. Sanofi noted that ...

SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...

according to Sanofi. It has also been approved to date in the EU, GB, and Canada. New data from the phase 3b, real-world HARMONIE study has confirmed the efficacy of Beyfortus in clinical trials ...

Zacks Research increased their FY2024 EPS estimates for shares of Sanofi in a report issued on Wednesday, November 13th.

The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.

Sanofi SNY is gearing up to announce its quarterly earnings on Friday, 2024-10-25. Here's a quick overview of what investors should know before the release. Analysts are estimating that Sanofi ...

Sanofi SNY reported third-quarter 2024 adjusted earnings of $1.57 per American depositary share, which beat the Zacks Consensus Estimate of $1.35 per share. Earnings of €2.86 per share rose 12.2 ...